News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

James A. Jorgenson, MS, RPh, FASHP

Articles by James A. Jorgenson, MS, RPh, FASHP

Edaravone in the Treatment of Amyotrophic Lateral Sclerosis: Efficacy and Access to Therapy - A Roundtable Discussion

ByBenjamin Rix Brooks, MD,James A. Jorgenson, MS, RPh, FASHP,Barbara J. Newhouse, MS, BSW,Jeremy M. Shefner, MD, PhD,Wendy Agnese, PharmD

April 25th 2018

Edaravone in the Treatment of Amyotrophic Lateral Sclerosis: Efficacy and Access to Therapy - A Roundtable Discussion Appendix

ByBenjamin Rix Brooks, MD,James A. Jorgenson, MS, RPh, FASHP,Barbara J. Newhouse, MS, BSW,Jeremy M. Shefner, MD, PhD,Wendy Agnese, PharmD

April 25th 2018

Latest Updated Articles

Edaravone in the Treatment of Amyotrophic Lateral Sclerosis: Efficacy and Access to Therapy - A Roundtable Discussion
Published: April 25th 2018 | Updated:
Edaravone in the Treatment of Amyotrophic Lateral Sclerosis: Efficacy and Access to Therapy - A Roundtable Discussion Appendix
Published: April 25th 2018 | Updated:

Trending on AJMC

TrumpRx Launch Brings Savings—and Uncertainty

5 Things to Know About the Oral GLP-1 Era

Exploring Identity, Appearance Experiences Among Patients With Alopecia

Even After 6 Years, Disease Progression Impacts Survival in Mantle Cell Lymphoma

Real-World Evidence Backs Acalabrutinib in CLL Care

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.

Alt Text

Alt Text